At least one company working on a coronavirus vaccine candidate is open to taking advantage of US Food and Drug Administration Commissioner Stephen Hahn’s willingness to consider emergency use authorization before the end of Phase III clinical trials.
When asked by the Pink Sheet about potential plans, several coronavirus vaccine sponsors were understandably coy about their regulatory strategy,...







